SERPING1 and hereditary angioedema: Our data suggest that C1-INH(IV) was used for routine HAE prophylaxis by at least 25% of patients, with the caveat that due to the nature of the prescription data analyzed, intended use (prophylactic vs on-demand) could only be assumed.